Her back hurt. That was the beginning, and it seemed like nothing. A dull, persistent ache that most adults over thirty have learned to absorb into the background noise of daily life — the consequence of a bad chair, a missed gym session, the slow indignities of a body aging under pressure. Then her pants wouldn't button. Not because she had gained weight in any obvious way, but because something inside her abdomen was growing, quietly and without mercy, filling the space behind her organs like a slow flood behind a dam. By the time she arrived at a specialist's office, the mass inside her was the size of a large melon. It was a retroperitoneal liposarcoma — a rare, aggressive cancer of the soft tissue that had spent months, possibly longer, expanding in anatomical silence. The Washington Post reported her story this week, and it is already resonating far beyond the medical community, because what happened to her is not a freak occurrence. It is a pattern, repeated thousands of times a year, in hospitals and clinics across every continent. The Body's Most Dangerous Hiding Place The retroperitoneal space is, in the bluntest terms, medicine's blind spot. Located behind the peritoneum — the membrane that lines the abdominal cavity — it houses the kidneys, adrenal glands, major blood vessels, and a sprawling network of lymph nodes and connective tissue. It is also a place where tumours can grow with startling freedom. Unlike cancers that develop in organs with defined boundaries, retroperitoneal sarcomas have room to expand in multiple directions before they press hard enough on surrounding structures to generate symptoms that feel genuinely alarming. Back pain is the most common presenting complaint. Abdominal fullness or bloating is the second. Neither of these sends most people — or most doctors — sprinting toward an oncology referral. They send people toward physiotherapists, gastroenterologists investigating irritable bowel syndrome, and pharmacists handing over bo